The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Otsuka Chemical, a manufacturer of chemicals, has agreed to acquire certain assets from Astellas Pharma relating to the active pharmaceutical ingredient (API), cefixime, a cephalosporin antibiotic.
Under the agreement, Otsuka will have rights to...
Fujifilm Corporation has announced an initial $10-million investment in a full-scale, fully integrated continuous processing facility for non-GMP manufacturing of biopharmaceuticals at the Billingham, UK site of Fujifilm Diosynth Biotechnologies,...
The latest news from CDMOs, CMOs, and suppliers featuring news from Thermo Fisher, Cambrex, Lonza, Vetter, Sterling Pharma, Fujifilm, PCI Pharma Services, Particle Sciences, Vibologics, iBio, and Parexel.
Chemicals/Chemical API...
Aldevron, a contract provider specializing in the production of nucleic acids, proteins, and antibodies, has announced expansion plans for a new 14-acre campus for gene and cell therapy manufacturing at its headquarters in Fargo, North Dakota....
Thermo Fisher Scientific has announced a $50-million investment in its global bioproduction capabilities to expand capacity for manufacturing single-use bioprocess container (BPC) systems at its site in Cramlington, United Kingdom and related...
WuXi Biologics, a contract biologics manufacturer, has signed a letter of intent for a strategic partnership with an unnamed vaccine maker for a 20-year supply contract, estimated to be worth more than $3 billion. Under the letter of intent, WuXi...
Catalent has completed its $1.2-billion acquisition of Paragon Bioservices, a contract provider of viral vector development and manufacturing services for gene therapies.
Paragon has development and manufacturing capabilities in adeno-associated...
The latest news from CDMOs, CMOs, and suppliers, featuring news from Fujifilm Diosynth Biotechnologies and Recipharma.
Biologics manufacturing
Fujifilm Diosynth Biotechnologies to Expand UK Site with New BioCampus
Fujifilm Diosynth...
WuXi Biologics, a contract biologics manufacturer, has begun construction of 1.3-million square foot manufacturing center in Chengdu, China, in southwest China.
The new integrated manufacturing center will include drug development and commercial...
Thermo Fisher Scientific has agreed to acquire a drug-substance manufacturing site in Cork, Ireland, from GlaxoSmithKline for approximately EUR 90 million ($100.6 million). Thermo says it will expand capacity at the Cork site for the development...
Catalent has announced it is investing up to $40 million at its manufacturing facility in Winchester, Kentucky to increase the site’s formulation and controlled-release tablet and capsule manufacturing capabilities and capacity.
New technologies...
The latest news from CDMOs, CMOs, and suppliers featuring news from Vetter, Catalent, Cambrex, Sharp and Biotechpharma.
Chemicals/Chemical API Manufacturing
Cambrex Completes Construction for High-Potency API Facility and QC Lab...
Catalent has agreed to acquire Paragon Bioservices, a Baltimore, Maryland-based contract provider of viral vector development and manufacturing services for gene therapies, for $1.2 billion.
Paragon has specialized expertise in adeno-associated...
The latest news from CDMOs, CMOS, and other suppliers featuring news from Wilmington PharmaTech, Insilico, ACG Group, Lonza
Chemicals/Chemical API Manufacturing
Wilmington PharmaTech To Invest $18 Million In New Research and Mfg Facility...
GE has entered into a definitive agreement to sell its BioPharma business to Danaher Corporation, a global science and technology company, headquartered in Washington D.C., for a total consideration of $21.4 billion, including $21 billion in cash...
